Short Summary
Intel Corporation et al. filed an IPR petition challenging Ericsson's patent on deblocking filter features, asserting obviousness over various prior art references. The core arguments focus on how asymmetric decision-making and specific offset equations are routine modifications of existing video compression techniques.
Detailed Summary
The petitioner, Intel Corporation et al., has initiated an Inter Partes Review (IPR) against Telefonaktiebolaget LM Ericsson's patent covering deblocking filter features used in video compression. The petition asserts that the claimed innovations—specifically asymmetric decision-making and specific offset equations—are obvious over a wide range of prior art, including Bjontegaard’s work, Aksu, Gonzalez, H.241, and various standards (B205/AAPA). The petitioner argues that substituting calculations or making minor variations in coefficient weights are routine design choices within the skill of a Person Having Ordinary Skill In The Art (POSITA), targeting 16 claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Intel Corporation et al. vs Telefonaktiebolaget LM Ericsson is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Apple Inc.vsImberaTek, LLC
Apple and ImberaTek have settled their dispute over a PCB insulation patent, filing a joint motion to terminate the pending IPR. The Board is asked to dismiss the case on good‑cause grounds before institution.
Microsoft CorporationvsProxense, LLC
Microsoft Corporation successfully petitioned for IPR against Proxense, LLC's patent (8646042) based on obviousness grounds. The Board granted institution after finding a reasonable likelihood of prevailing on multiple combinations of prior art references.
Imperative Care, Inc.vsInari Medical, Inc.
The PTAB held that all nine claims of Inari Medical’s hemostasis‑valve patent are unpatentable. Petitioner Imperative Care proved anticipation and obviousness over Schaffer, Hartley, Eller and Garrison, with the Board emphasizing that the claimed filament must be flexible.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 B2 embolism‑treatment patent after finding Imperative Care likely to prevail on at least one claim. All 15 claims are now under review.
SAMSUNG ELECTRONICS CO., LTD. et al.vsiCashe, Inc.
Samsung Electronics petitions the PTAB Director to rehear a discretionary denial of institution in IPR2025-00642, arguing that recent USPTO guidance changes violated the APA and due‑process rights. The petition contends the Board ignored Samsung’s Sotera stipulation and misapplied “settled expectations.”
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.